Yohimbine
Internal ID | d4f3ade2-6c78-4816-a9c1-c128b7afedb2 |
Taxonomy | Alkaloids and derivatives > Yohimbine alkaloids |
IUPAC Name | methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate |
SMILES (Canonical) | COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O |
SMILES (Isomeric) | COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O |
InChI | InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1 |
InChI Key | BLGXFZZNTVWLAY-SCYLSFHTSA-N |
Popularity | 10,937 references in papers |
Molecular Formula | C21H26N2O3 |
Molecular Weight | 354.40 g/mol |
Exact Mass | 354.19434270 g/mol |
Topological Polar Surface Area (TPSA) | 65.60 Ų |
XlogP | 2.90 |
Atomic LogP (AlogP) | 2.65 |
H-Bond Acceptor | 4 |
H-Bond Donor | 2 |
Rotatable Bonds | 1 |
Yohimbin |
146-48-5 |
Quebrachin |
Quebrachine |
Corynine |
APHRODINE |
Yohimbic acid methyl ester |
Aphrosol |
(+)-Yohimbine |
Yohimex |
There are more than 10 synonyms. If you wish to see them all click here. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9856 | 98.56% |
Caco-2 | + | 0.9312 | 93.12% |
Blood Brain Barrier | - | 0.8500 | 85.00% |
Human oral bioavailability | - | 0.9000 | 90.00% |
Subcellular localzation | Mitochondria | 0.7506 | 75.06% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.9368 | 93.68% |
OATP1B3 inhibitior | + | 0.9479 | 94.79% |
MATE1 inhibitior | - | 0.9400 | 94.00% |
OCT2 inhibitior | - | 0.8000 | 80.00% |
BSEP inhibitior | + | 0.9071 | 90.71% |
P-glycoprotein inhibitior | - | 0.7032 | 70.32% |
P-glycoprotein substrate | + | 0.9344 | 93.44% |
CYP3A4 substrate | + | 0.7976 | 79.76% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | + | 0.4913 | 49.13% |
CYP3A4 inhibition | - | 0.8333 | 83.33% |
CYP2C9 inhibition | - | 0.9071 | 90.71% |
CYP2C19 inhibition | - | 0.9094 | 90.94% |
CYP2D6 inhibition | + | 0.8931 | 89.31% |
CYP1A2 inhibition | - | 0.9045 | 90.45% |
CYP2C8 inhibition | - | 0.5764 | 57.64% |
CYP inhibitory promiscuity | - | 0.8682 | 86.82% |
UGT catelyzed | + | 0.9000 | 90.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.6191 | 61.91% |
Eye corrosion | - | 0.9911 | 99.11% |
Eye irritation | - | 0.9861 | 98.61% |
Skin irritation | - | 0.7617 | 76.17% |
Skin corrosion | - | 0.9523 | 95.23% |
Ames mutagenesis | - | 0.6378 | 63.78% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.8763 | 87.63% |
Micronuclear | + | 0.6100 | 61.00% |
Hepatotoxicity | - | 0.8500 | 85.00% |
skin sensitisation | - | 0.9054 | 90.54% |
Respiratory toxicity | + | 0.9778 | 97.78% |
Reproductive toxicity | + | 0.9778 | 97.78% |
Mitochondrial toxicity | + | 0.9875 | 98.75% |
Nephrotoxicity | + | 0.7565 | 75.65% |
Acute Oral Toxicity (c) | II | 0.4961 | 49.61% |
Estrogen receptor binding | + | 0.6268 | 62.68% |
Androgen receptor binding | + | 0.7850 | 78.50% |
Thyroid receptor binding | - | 0.5760 | 57.60% |
Glucocorticoid receptor binding | - | 0.6381 | 63.81% |
Aromatase binding | - | 0.8514 | 85.14% |
PPAR gamma | - | 0.8545 | 85.45% |
Honey bee toxicity | - | 0.8352 | 83.52% |
Biodegradation | - | 0.8500 | 85.00% |
Crustacea aquatic toxicity | + | 0.6000 | 60.00% |
Fish aquatic toxicity | - | 0.5922 | 59.22% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL256 | P0DMS8 | Adenosine A3 receptor |
95 nM |
IC50 |
PMID: 16250647
|
CHEMBL229 | P35348 | Alpha-1a adrenergic receptor |
29 nM 1057 nM |
Ki Ki |
via Super-PRED
PMID: 7562902 |
CHEMBL232 | P35368 | Alpha-1b adrenergic receptor |
7.2 nM 1.1 nM 517 nM 7.2 nM |
Ki Ki Ki Ki |
PMID: 7658428
PMID: 7658428 via Super-PRED via Super-PRED |
CHEMBL223 | P25100 | Alpha-1d adrenergic receptor |
1013 nM 253 nM 1.6 nM 3.5 nM |
IC50 Ki Ki Ki |
via CMAUP
via Super-PRED via Super-PRED via Super-PRED |
CHEMBL1867 | P08913 | Alpha-2a adrenergic receptor |
8.4 nM 6.151 nM 0.42 nM |
IC50 IC50 Ki |
PMID: 23403082
via CMAUP via Super-PRED |
CHEMBL1942 | P18089 | Alpha-2b adrenergic receptor |
1.16 nM 17 nM |
Ki IC50 |
via Super-PRED
via CMAUP |
CHEMBL1916 | P18825 | Alpha-2c adrenergic receptor |
16 nM 0.5 nM 36 nM |
IC50 Ki IC50 |
via Super-PRED
via Super-PRED via CMAUP |
CHEMBL289 | P10635 | Cytochrome P450 2D6 |
8.4 nM 2031.7 nM |
IC50 IC50 |
PMID: 15481972
via CMAUP |
CHEMBL1781 | P11387 | DNA topoisomerase I |
30000 nM |
IC50 |
PMID: 15974606
|
CHEMBL217 | P14416 | Dopamine D2 receptor |
2060 nM |
IC50 |
via CMAUP
|
CHEMBL1293235 | P02545 | Prelamin-A/C |
89.1 nM |
Potency |
via Super-PRED
|
CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR |
14689.2 nM |
Potency |
via CMAUP
|
CHEMBL1833 | P41595 | Serotonin 2b (5-HT2b) receptor |
74 nM |
IC50 |
via CMAUP
|
CHEMBL3371 | P50406 | Serotonin 6 (5-HT6) receptor |
1689 nM |
IC50 |
via CMAUP
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.57% | 96.09% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.19% | 91.11% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 95.93% | 85.14% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 95.05% | 95.56% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.87% | 94.45% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.92% | 97.09% |
CHEMBL2581 | P07339 | Cathepsin D | 91.35% | 98.95% |
CHEMBL1914 | P06276 | Butyrylcholinesterase | 90.98% | 95.00% |
CHEMBL2535 | P11166 | Glucose transporter | 88.62% | 98.75% |
CHEMBL228 | P31645 | Serotonin transporter | 88.51% | 95.51% |
CHEMBL5028 | O14672 | ADAM10 | 86.11% | 97.50% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 84.35% | 83.82% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 81.97% | 99.23% |
CHEMBL1821 | P08173 | Muscarinic acetylcholine receptor M4 | 80.04% | 94.08% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
PubChem | 8969 |
NPASS | NPC49196 |
ChEMBL | CHEMBL15245 |
LOTUS | LTS0002176 |
wikiData | Q412226 |